Markets:

Overview

News

Currencies

International

Treasuries

Theravance Biopharma, Inc. - Ordinary Shares (NQ:TBPH)

18.73 +0.16 (+0.86%)

Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Theravance Biopharma, Inc. - Ordinary Shares

< Previous 1 2 3 4 5 6 Next >

60 Biggest Movers From Yesterday ↗

August 25, 2021

Gainers Triple-S Management Corporation (NYSE: GTS) shares surged 45.5% to close at $35.20 on Tuesday. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield...

Via Benzinga

Here's Why Theravance Biopharma Stock Is Tanking Today ↗

August 24, 2021

The company's second clinical-trial flop in as many months isn't sitting well with investors.

Via The Motley Fool

Mid-Afternoon Market Update: Nasdaq Rises 75 Points; Palo Alto Networks Shares Jump On Upbeat Earnings ↗

August 24, 2021

Toward the end of trading Tuesday, the Dow traded up 0.26% to 35,427.95 while the NASDAQ rose 0.50% to 15,018.26. The S&P also rose, gaining 0.25% to 4,490.82. The U.S. has...

Via Benzinga

Topics Stocks

Vaccine Optimism Pushes S&P 500, Nasdaq to Fresh Intraday Highs ↗

August 24, 2021

This week is so far proving to be much better than the last one, as the three major indexes look to extend yesterday's gains.

Via Talk Markets

Topics Stocks

Analysts Slash Price Targets After Theravance's Failed Ulcerative Colitis Study ↗

August 24, 2021

Analysts have lowered the price target and downgraded Theravance Biopharma Inc (NASDAQ:

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 24, 2021

Gainers Triple-S Management (NYSE:GTS) shares moved upwards by 45.3% to $35.15 during Tuesday's regular session. As of 12:30 EST, Triple-S Management's stock is...

Via Benzinga

Mid-Day Market Update: Crude Oil Rises Over 2%; Theravance Biopharma Shares Slide ↗

August 24, 2021

Midway through trading Tuesday, the Dow traded up 0.09% to 35,368.20 while the NASDAQ rose 0.40% to 15,001.95. The S&P also rose, gaining 0.14% to 4,486.01. The U.S. has the...

Via Benzinga

Topics Stocks

What 10 Analyst Ratings Have To Say About Theravance Biopharma ↗

August 24, 2021

Theravance Biopharma (NASDAQ:TBPH) has observed the following analyst rati...

Via Benzinga

38 Stocks Moving In Tuesday's Mid-Day Session ↗

August 24, 2021

Gainers Triple-S Management Corporation (NYSE: GTS) shares jumped 45.3% to $35.15. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield of Florida Inc,...

Via Benzinga

Mid-Morning Market Update: Markets Edge Higher; Best Buy Earnings Top Estimates ↗

August 24, 2021

Following the market opening Tuesday, the Dow traded up 0.11% to 35,374.12 while the NASDAQ rose 0.43% to 15,006.17. The S&P also rose, gaining 0.22% to 4,489.23. The U.S. has...

Via Benzinga

Topics Stocks

Theravance Stock Crashes; Can Longer Testing Salvage Its J&J-Partnered Drug? ↗

August 24, 2021

Theravance said late Monday its ulcerative colitis treatment failed in midstage testing, and the biotech stock plummeted early Tuesday.

Via Investor's Business Daily

Stocks That Hit 52-Week Lows On Tuesday ↗

August 24, 2021

During Tuesday's morning trading, 20 companies set new 52-week lows. Noteables: The largest company in terms of market cap to set a new 52-week low was Campbell...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2021 ↗

August 24, 2021

Upgrades Canaccord Genuity upgraded the previous rating for Precision Drilling Corp (NYSE:

Via Benzinga

10 Biggest Price Target Changes For Tuesday ↗

August 24, 2021

Benchmark cut the price target for JD.com, Inc. (NASDAQ:

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 24, 2021

Gainers Triple-S Management (NYSE:GTS) stock moved upwards by 44.27% to $34.9 during Tuesday's pre-market session. The market value of their outstanding shares is at $...

Via Benzinga

Theravance Stock Plunges As JAK Inhibitor Flops Ulcerative Colitis Study ↗

August 24, 2021

Theravance Biopharma Inc's (NASDAQ: TBPH) Izencitinib, a "gut-selective" JAK inhibitor developed for ulcerative colitis and Crohn's disease, failed a...

Via Benzinga

Theravance Biopharma, inc (TBPH) Q2 2021 Earnings Call Transcript ↗

August 04, 2021

TBPH earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Recap: Theravance Biopharma Q2 Earnings ↗

August 03, 2021

Shares of Theravance Biopharma (NASDAQ:TBPH) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 20.00% year over...

Via Benzinga

The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal ↗

August 24, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (...

Via Benzinga

Know When To Hold 'Em, Know When To Fold 'Em ... ↗

August 02, 2021

A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks.

Via Talk Markets

Stocks That Hit 52-Week Lows On Monday ↗

August 09, 2021

Before 10 a.m. ET Monday, 63 stocks made new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was PACCAR (NASDAQ:PCAR)....

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

August 02, 2021

Monday morning, 34 companies reached new 52-week lows. Things to Consider: Las Vegas Sands (NYSE:LVS) was the largest, in terms of market cap, to set a new 52-week...

Via Benzinga

The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business ↗

August 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Earnings Scheduled For August 3, 2021 ↗

August 03, 2021

Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to...

Via Benzinga

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗

July 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

July 19, 2021

Stocks That Hit 52-Week Lows On Monday Monday morning, 285 companies reached new 52-week lows. Noteworthy Points: The largest company by market cap to set a new 52-week...

Via Benzinga

The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study ↗

July 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:...

Via Benzinga

Topics Stocks

Stocks That Hit 52-Week Lows On Thursday ↗

July 15, 2021

During the morning session on Thursday, 152 stocks hit new 52-week lows. Interesting Points: TotalEnergies (NYSE:TTE) was the biggest company by market cap to set a new 52...

Via Benzinga

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs ↗

July 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,...

Via Benzinga

Topics Product Recall

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Theravance Biopharma, Inc. - Ordinary Shares (NQ:TBPH)

All News about Theravance Biopharma, Inc. - Ordinary Shares

Starting at $3.75/week.

Subscribe Today